# Chinese biopharmaceutical global expansion and growth > Live situation record from CLSTR: https://clstr.news/situations/chinese-biopharmaceutical-global-expansion-and-growth > Updated: 2026-08-31T13:34:45.000Z. Sources: 8. Developments: 2. Chinese biopharmaceutical companies are reporting significant financial growth and expanding their global presence through international licensing deals and research funding. In mid-2026, 3S Bio reported a 3.9% year-over-year increase in interim revenue to RMB 4.53 billion, driven by a 43% surge in overseas sales. The company is also advancing a partnership with Pfizer for an immuno-oncology therapeutic. Similarly, Sino Biopharmaceutical launched the SBP Group brand to transition into a global innovator, having completed out-licensing transactions with multinational corporations totaling over US$7 billion in potential value. Other firms in the sector are also securing major milestones. Simnova Biotech secured approximately USD 59.5 million in Series B funding to advance cell therapy research, including CAR-NK and In Vivo CAR-T platforms. Additionally, Simcere Zaiming entered an exclusive global licensing agreement with Roche for a tri-specific T-cell engager, a deal valued at up to USD 1.53 billion. ## Timeline ### 2026-08-31: Biotech firms Simnova and Simcere Zaiming secure major funding and licensing deals Simnova Biotech raised USD 59.5 million for cell therapy development, while Simcere Zaiming signed a USD 1.53 billion licensing deal with Roche for a tri-specific antibody. 4 sources. https://clstr.news/cluster/biotech-firms-simnova-and-simcere-zaiming-secure-major-funding-and-licensing-deals ### 2026-08-19: Biopharmaceutical firms 3S Bio and Sino Biopharmaceutical report growth and global expansion Chinese biopharmaceutical firms 3S Bio and Sino Biopharmaceutical report strong 2026 interim results and expanded global strategies, including major licensing deals with Pfizer and Sanofi. 4 sources. https://clstr.news/cluster/biopharmaceutical-firms-3s-bio-and-sino-biopharmaceutical-report-growth-and-global-expansion --- Cite as: Chinese biopharmaceutical global expansion and growth. CLSTR, https://clstr.news/situations/chinese-biopharmaceutical-global-expansion-and-growth